{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T18:30:38Z","timestamp":1785695438090,"version":"3.56.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020374","name":"Ministry of AYUSH, Government of India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["A.11019\/03\/2020-NMPB-IV-A"],"award-info":[{"award-number":["A.11019\/03\/2020-NMPB-IV-A"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR40738\/TRM\/120\/486\/2020"],"award-info":[{"award-number":["BT\/PR40738\/TRM\/120\/486\/2020"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bbalip.2023.159348","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T01:47:37Z","timestamp":1685929657000},"page":"159348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of lipid signatures in the plasma and insulin-sensitive tissues of the C57BL\/6J mice fed on obesogenic diets"],"prefix":"10.1016","volume":"1868","author":[{"given":"Jyoti","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hobby","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonu Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Swapna","family":"Kasarla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumalya","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R. Kamla","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashwant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Dikshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0005","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/EBC20200067","article-title":"Mammalian lipids: structure, synthesis and function","volume":"65","author":"Cockcroft","year":"2021","journal-title":"Essays Biochem."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ajcn\/73.4.703","article-title":"Occasional physical inactivity combined with a high-fat diet may be important in the development and maintenance of obesity in human subjects","volume":"73","author":"Shepard","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0015","first-page":"224","article-title":"Obesity and sedentary lifestyles: risk for cardiovascular disease in women","volume":"39","author":"Barnes","year":"2012","journal-title":"Tex. Heart Inst. J."},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tem.2022.02.001","article-title":"Lipids and lipoproteins in cardiovascular diseases: a classification","volume":"33","author":"Bhargava","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"van Meer","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"issue":"12","key":"10.1016\/j.bbalip.2023.159348_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13081","article-title":"Diet-induced rodent models of obesity-related metabolic disorders-a guide to a translational perspective","volume":"21","author":"Preguica","year":"2020","journal-title":"Obes. Rev."},{"key":"10.1016\/j.bbalip.2023.159348_bb0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-61779-430-8_27","article-title":"A mouse model of diet-induced obesity and insulin resistance","volume":"821","author":"Wang","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0045","doi-asserted-by":"crossref","first-page":"19556","DOI":"10.1038\/s41598-019-55987-x","article-title":"Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL\/6 mice","volume":"9","author":"Lang","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbalip.2023.159348_bb0050","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2337\/db16-0251","article-title":"De novo lipogenesis products and endogenous lipokines","volume":"65","author":"Yilmaz","year":"2016","journal-title":"Diabetes."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10409231003667500","article-title":"Genetic control of de novo lipogenesis: role in diet-induced obesity","volume":"45","author":"Strable","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbalip.2023.159348_bb0060","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/ncomms2537","article-title":"De novo lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health","volume":"4","author":"Eissing","year":"2013","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bbalip.2023.159348_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101383","article-title":"Regulation and metabolic significance of de novo lipogenesis in adipose tissues","volume":"10","author":"Song","year":"2018","journal-title":"Nutrients."},{"key":"10.1016\/j.bbalip.2023.159348_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcdb.2020.02.012","article-title":"Tracing insights into de novo lipogenesis in liver and adipose tissues","volume":"108","author":"Wallace","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbalip.2023.159348_bb0075","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/JME-18-0023","article-title":"Defining lipid mediators of insulin resistance - controversies and challenges","volume":"62","author":"Metcalfe","year":"2018","journal-title":"J. Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.bbalip.2023.159348_bb0080","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J. Hepatol."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0085","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cmet.2016.11.001","article-title":"Applications and limitations of mouse models for understanding human atherosclerosis","volume":"25","author":"von Scheidt","year":"2017","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0095","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209684","article-title":"Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis","volume":"17","author":"Norheim","year":"2021","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbalip.2023.159348_bb0100","doi-asserted-by":"crossref","first-page":"16984","DOI":"10.1038\/srep16984","article-title":"Lipidomic profiling of liver tissue from obesity-prone and obesity-resistant mice fed a high fat diet","volume":"5","author":"Nam","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2023.159348_bb0105","doi-asserted-by":"crossref","first-page":"7122738","DOI":"10.1155\/2022\/7122738","article-title":"Age- and diet-dependent changes in hepatic lipidomic profiles of phospholipids in male mice: age acceleration in Cyp2b-null mice","volume":"2022","author":"Heintz","year":"2022","journal-title":"J. Lipids"},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cels.2018.05.009","article-title":"Genetic regulation of plasma lipid species and their association with metabolic phenotypes","volume":"6","author":"Jha","year":"2018","journal-title":"Cell Syst."},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cels.2018.05.016","article-title":"Systems analyses reveal physiological roles and genetic regulators of liver lipid species","volume":"6","author":"Jha","year":"2018","journal-title":"Cell Syst."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0120","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaim.2021.05.005","article-title":"An Ayurvedic formulation of Emblica officinalis and Curcuma longa alleviates insulin resistance in diabetic rats: involvement of curcuminoids and polyphenolics","volume":"12","author":"Panda","year":"2021","journal-title":"J. Ayurveda Integr. Med."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0125","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11306-016-1157-8","article-title":"A relative quantitative positive\/negative ion switching method for untargeted lipidomics via high resolution LC-MS\/MS from any biological source","volume":"13","author":"Breitkopf","year":"2017","journal-title":"Metabolomics."},{"key":"10.1016\/j.bbalip.2023.159348_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112357","article-title":"Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids","volume":"144","author":"Sarkar","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbalip.2023.159348_bb0145","doi-asserted-by":"crossref","first-page":"635175","DOI":"10.3389\/fendo.2021.635175","article-title":"Sphingolipids as a culprit of mitochondrial dysfunction in insulin resistance and type 2 diabetes","volume":"12","author":"Roszczyc-Owsiejczuk","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbalip.2023.159348_bb0150","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fendo.2019.00577","article-title":"The role of ceramides in insulin resistance","volume":"10","author":"Sokolowska","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/oxfordjournals.bmb.a011629","article-title":"Ceramide signaling in apoptosis","volume":"53","author":"Haimovitz-Friedman","year":"1997","journal-title":"Br. Med. Bull."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13238-017-0437-z","article-title":"Carboxylesterases in lipid metabolism: from mouse to human","volume":"9","author":"Lian","year":"2018","journal-title":"Protein Cell"},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell."},{"issue":"5081","key":"10.1016\/j.bbalip.2023.159348_bb0170","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0021-9150(97)00165-2","article-title":"C57BL\/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis","volume":"136","author":"Schreyer","year":"1998","journal-title":"Atherosclerosis."},{"issue":"11","key":"10.1016\/j.bbalip.2023.159348_bb0180","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1073\/pnas.84.11.3763","article-title":"Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice","volume":"84","author":"Paigen","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0185","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2023.159348_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/520618","article-title":"Sphingolipids in high fat diet and obesity-related diseases","volume":"2015","author":"Choi","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12967-018-1548-x","article-title":"Triglyceride profiling in adipose tissues from obese insulin sensitive, insulin resistant and type 2 diabetes mellitus individuals","volume":"16","author":"Al-Sulaiti","year":"2018","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.bbalip.2023.159348_bb0200","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2116\/analsci.19P442","article-title":"Untargeted lipidomic analysis of plasma from high-fat diet-induced obese rats using UHPLC-linear trap quadrupole-orbitrap MS","volume":"36","author":"Gowda","year":"2020","journal-title":"Anal. Sci."},{"key":"10.1016\/j.bbalip.2023.159348_bb0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molmet.2019.01.009","article-title":"Comprehensive and quantitative analysis of white and brown adipose tissue by shotgun lipidomics","volume":"22","author":"Grzybek","year":"2019","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0210","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/oby.21448","article-title":"Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight\/obesity in humans","volume":"24","author":"Tonks","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bbalip.2023.159348_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/104132","article-title":"Does diacylglycerol accumulation in fatty liver disease cause hepatic insulin resistance?","volume":"2015","author":"Finck","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0220","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology."},{"issue":"11","key":"10.1016\/j.bbalip.2023.159348_bb0225","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s42255-021-00493-6","article-title":"Lipolysis: cellular mechanisms for lipid mobilization from fat stores","volume":"3","author":"Grabner","year":"2021","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0230","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/acs.jproteome.5b00213","article-title":"A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins","volume":"14","author":"Gordon","year":"2015","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b15-00716","article-title":"Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis","volume":"39","author":"Morita","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbalip.2023.159348_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117601","article-title":"ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK\/mTOR mediated autophagy","volume":"252","author":"Lu","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0245","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1073\/pnas.89.5.1750","article-title":"Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia","volume":"89","author":"Shimano","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.bbalip.2023.159348_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218067","article-title":"The emerging and diverse roles of bis(monoacylglycero) phosphate lipids in cellular physiology and disease","volume":"21","author":"Showalter","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0255","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1194\/jlr.M093351","article-title":"Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans","volume":"60","author":"Grabner","year":"2019","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0260","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/10409230903193307","article-title":"The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease","volume":"44","author":"Fadeel","year":"2009","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.bbalip.2023.159348_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2016.27","article-title":"Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects","volume":"6","author":"Ma","year":"2016","journal-title":"Nutr. Diabetes"},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0270","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.cdd.4402125","article-title":"Endoplasmic reticulum stress-induced cell death mediated by the proteasome","volume":"14","author":"Egger","year":"2007","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0275","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1016\/j.cub.2007.11.024","article-title":"Apoptotic cell recognition: will the real phosphatidylserine receptor(s) please stand up?","volume":"18","author":"Bratton","year":"2008","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbalip.2023.159348_bb0280","series-title":"Phosphatidylserine, another player in macrophage recruitment in white adipose tissue?","first-page":"2","volume":"2010","author":"Renes","year":"2010"},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0285","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2016.07.045","article-title":"The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans","volume":"65","author":"Luukkonen","year":"2016","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.bbalip.2023.159348_bb0290","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0295","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0300","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","article-title":"The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis","volume":"3","author":"Li","year":"2006","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0305","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.chroma.2008.04.031","article-title":"Quantitative profiling of phosphatidylcholine and phosphatidylethanolamine in a steatosis\/fibrosis model of rat liver by nanoflow liquid chromatography\/tandem mass spectrometry","volume":"1194","author":"Ahn","year":"2008","journal-title":"J. Chromatogr. A"},{"issue":"12","key":"10.1016\/j.bbalip.2023.159348_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/cells7120230","article-title":"Decreasing phosphatidylcholine on the surface of the lipid droplet correlates with altered protein binding and steatosis","volume":"7","author":"Listenberger","year":"2018","journal-title":"Cells."},{"issue":"9 Pt B","key":"10.1016\/j.bbalip.2023.159348_bb0315","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2014.09.027","article-title":"Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice","volume":"118","author":"Lee","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.bbalip.2023.159348_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.797923","article-title":"Regression of liver steatosis following phosphatidylcholine administration: a review of molecular and metabolic pathways involved","volume":"13","author":"Osipova","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0330","article-title":"Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia","volume":"7","author":"Maev","year":"2020","journal-title":"BMJ Open Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0335","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41467-020-20500-w","article-title":"High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance","volume":"12","author":"Kumar","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0340","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM199301283280404","article-title":"The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids","volume":"328","author":"Borkman","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0345","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0026-0495(00)91455-0","article-title":"Changes in phosphatidylcholine fatty acid composition are associated with altered skeletal muscle insulin responsiveness in normal man","volume":"49","author":"Clore","year":"2000","journal-title":"Metabolism."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0350","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.plipres.2013.07.002","article-title":"Lipids of mitochondria","volume":"52","author":"Horvath","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2023.159348_bb0355","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.1038\/srep11737","article-title":"Enzymatic measurement of phosphatidylglycerol and cardiolipin in cultured cells and mitochondria","volume":"5","author":"Morita","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0360","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1096\/fj.201801897R","article-title":"Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity","volume":"33","author":"Kayser","year":"2019","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0365","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3746\/pnf.2020.25.2.113","article-title":"The influence of the gut microbiome on obesity in adults and the role of probiotics, prebiotics, and synbiotics for weight loss","volume":"25","author":"Aoun","year":"2020","journal-title":"Prev. Nutr. Food Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.bbalip.2023.159348_bb0370","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jfma.2018.07.009","article-title":"The gut microbiome in obesity","volume":"118","author":"Tseng","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"issue":"8","key":"10.1016\/j.bbalip.2023.159348_bb0375","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1194\/jlr.R700018-JLR200","article-title":"Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes","volume":"49","author":"Schlame","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2023.159348_bb0380","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcell.2017.00090","article-title":"Role of cardiolipin in mitochondrial signaling pathways","volume":"5","author":"Dudek","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.bbalip.2023.159348_bb0385","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbabio.2007.07.011","article-title":"Mitochondrial dysfunction in rat with nonalcoholic fatty liver involvement of complex I, reactive oxygen species and cardiolipin","volume":"1767","author":"Petrosillo","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bbalip.2023.159348_bb0390","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.2337\/db16-0114","article-title":"Impaired cardiolipin biosynthesis prevents hepatic steatosis and diet-induced obesity","volume":"65","author":"Cole","year":"2016","journal-title":"Diabetes."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0395","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biochi.2012.10.009","article-title":"Novel bioactive glycerol-based lysophospholipids: new data\u2014new insight into their function","volume":"95","author":"Grzelczyk","year":"2013","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0400","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3945\/ajcn.116.130872","article-title":"Impairment of lysophospholipid metabolism in obesity: altered plasma profile and desensitization to the modulatory properties of n-3 polyunsaturated fatty acids in a randomized controlled trial","volume":"104","author":"Del Bas","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbalip.2023.159348_bb0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12986-018-0288-5","article-title":"Changes in lysophospholipids and liver status after weight loss: the RESMENA study","volume":"15","author":"Cantero","year":"2018","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0415","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bbalip.2013.11.013","article-title":"Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function","volume":"1841","author":"Hollie","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0420","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/pr100892r","article-title":"Metabolomic analysis of livers and serum from high-fat diet induced obese mice","volume":"10","author":"Kim","year":"2011","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030579","article-title":"Lysophosphatidylethanolamine affects lipid accumulation and metabolism in a human liver-derived cell line","volume":"14","author":"Yamamoto","year":"2022","journal-title":"Nutrients."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0430","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00216-020-02996-9","article-title":"Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry","volume":"413","author":"Yamamoto","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0440","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0445","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MPG.0000000000002875","article-title":"Lipidomics in nonalcoholic fatty liver disease: exploring serum lipids as biomarkers for pediatric nonalcoholic fatty liver disease","volume":"71","author":"Draijer","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0450","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.plipres.2012.03.001","article-title":"Emerging roles for lysophosphatidylserine in resolution of inflammation","volume":"51","author":"Frasch","year":"2012","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0455","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1096\/fj.14-255901","article-title":"Acylcarnitines: potential implications for skeletal muscle insulin resistance","volume":"29","author":"Aguer","year":"2015","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes."},{"issue":"15","key":"10.1016\/j.bbalip.2023.159348_bb0465","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1177\/15353702211009493","article-title":"Association of plasma acylcarnitines with insulin sensitivity, insulin secretion, and prediabetes in a biracial cohort","volume":"246","author":"Owei","year":"2021","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0470","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.1152\/ajpendo.00134.2015","article-title":"Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans","volume":"309","author":"Bergman","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bbalip.2023.159348_bb0475","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","article-title":"Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans","volume":"18","author":"Wigger","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2023.159348_bb0480","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fendo.2020.00483","article-title":"Ceramide synthases are attractive drug targets for treating metabolic diseases","volume":"11","author":"Raichur","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.bbalip.2023.159348_bb0485","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/liv.12331","article-title":"Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease","volume":"34","author":"Kurek","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2023.159348_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115157","article-title":"Ceramide de novo synthesis in non-alcoholic fatty liver disease: pathogenic mechanisms and therapeutic perspectives","volume":"202","author":"Yu","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040792","article-title":"Roles of ceramides in non-alcoholic fatty liver disease","volume":"10","author":"Hajduch","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbalip.2023.159348_bb0500","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fendo.2019.00665","article-title":"Inhibiting ceramide synthesis attenuates hepatic steatosis and fibrosis in rats with non-alcoholic fatty liver disease","volume":"10","author":"Jiang","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"48","key":"10.1016\/j.bbalip.2023.159348_bb0505","doi-asserted-by":"crossref","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","article-title":"Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas","volume":"284","author":"Imgrund","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.bbalip.2023.159348_bb0510","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1074\/jbc.M109.077610","article-title":"A critical role for ceramide synthase 2 in liver homeostasis: II. Insights into molecular changes leading to hepatopathy","volume":"285","author":"Pewzner-Jung","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0515","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","article-title":"CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity","volume":"177","author":"Hammerschmidt","year":"2019","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2023.159348_bb0520","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fphar.2017.00579","article-title":"Sphingosine 1-phosphate signaling as a target in hepatic fibrosis therapy","volume":"8","author":"Gonzalez-Fernandez","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbalip.2023.159348_bb0525","doi-asserted-by":"crossref","first-page":"32119","DOI":"10.1038\/srep32119","article-title":"Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.bbalip.2023.159348_bb0530","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1074\/jbc.M807800200","article-title":"Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice","volume":"284","author":"Deevska","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbalip.2023.159348_bb0535","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jhep.2014.09.023","article-title":"Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways","volume":"62","author":"Garcia-Ruiz","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bbalip.2023.159348_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030722","article-title":"Divergent role of sphingosine 1-phosphate in liver health and disease","volume":"19","author":"Kleuser","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbalip.2023.159348_bb0545","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/dmd.111.043877","article-title":"Transcription factor-mediated regulation of carboxylesterase enzymes in livers of mice","volume":"40","author":"Zhang","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bbalip.2023.159348_bb0550","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nchembio.1429","article-title":"Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes","volume":"10","author":"Dominguez","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.bbalip.2023.159348_bb0555","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: a comprehensive review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.bbalip.2023.159348_bb0560","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1194\/jlr.M092544","article-title":"Ces1d deficiency protects against high-sucrose diet-induced hepatic triacylglycerol accumulation","volume":"60","author":"Lian","year":"2019","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.bbalip.2023.159348_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049515","article-title":"Carboxylesterase1\/esterase-x regulates chylomicron production in mice","volume":"7","author":"Quiroga","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbalip.2023.159348_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273049","article-title":"Proteomic analysis of the effect of high-fat-diet and voluntary physical activity on mouse liver","volume":"17","author":"So","year":"2022","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.bbalip.2023.159348_bb0575","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1089\/ars.2014.6098","article-title":"Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology","volume":"22","author":"Spickett","year":"2015","journal-title":"Antioxid. Redox Signal."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198123000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198123000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:15:39Z","timestamp":1761387339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198123000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1388198123000720"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2023.159348","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of lipid signatures in the plasma and insulin-sensitive tissues of the C57BL\/6J mice fed on obesogenic diets","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2023.159348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"159348"}}